Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01522339 · ClinicalTrials.gov registry record · NA
Pilot Study: Safety of a Customized MRI System for Neonatal Imaging
A NA study of Safety of a Customized NICU MRI System, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT01522339: Completed NA study of Safety of a Customized NICU MRI System, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT01522339 is a NA study of Safety of a Customized NICU MRI System that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01522339, a NA study of Safety of a Customized NICU MRI System, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the safety of a customized MRI scanner and gather preliminary data on image quality in a group of 10 medically stable infants admitted to the Neonatal Intensive Care Unit (NICU) at Cincinnati Children's Hospital Medical Center (CCHMC).
Primary Outcome
Heart rate and oxygen saturation will be measured every 15+/- 5 minutes. The infants' temperatures will be taken immediately before the MRI and again immediately after the MRI. A physical exam will be performed both immediately before and immediately after the MRI to assess for any physical changes.
Conditions Studied
Interventions
- DEVICE GE OPTIMA MR430s with HDX/GE Electronics
Study Locations (1)
Ohio
- NICU, Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT01522339 record still lists
NCT01522339 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Safety of a Customized NICU MRI System appearing as the primary indexed condition, and to 1 intervention - of which GE OPTIMA MR430s with HDX/GE Electronics is the first listed.
NCT01522339 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT01522339 about?
NCT01522339 is a clinical study titled "Pilot Study: Safety of a Customized MRI System for Neonatal Imaging". The purpose of this study is to determine the safety of a customized MRI scanner and gather preliminary data on image quality in a group of 10 medically stable infants admitted to the Neonatal Intensive Care Unit (NICU) at Cincinnati Children's Hospital Medical Center (CCHMC).
What is the current status of trial NCT01522339?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-02. Estimated completion is 2012-04.
What conditions does trial NCT01522339 study?
This clinical trial studies the following conditions: Safety of a Customized NICU MRI System.
What interventions are being tested in trial NCT01522339?
The interventions under investigation include: GE OPTIMA MR430s with HDX/GE Electronics (DEVICE).
Who is sponsoring clinical trial NCT01522339?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01522339 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01522339's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia